Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population

G. Damiani; R. Finelli; K. Kridin; A. Pacifico; N. L. Bragazzi; P. Malagoli; G. Fabbrocini; E. Bonifazi; F. Mazzotta; C. Lovati; P. Savoia; L. C. Gironi; M. Morello; T. Davidson; A. Watad; F. Goker; C. Mortellaro; M. Del Fabbro

doi:10.26355/EURREV_202212_30798

Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population

G. Damiani, R. Finelli, K. Kridin, A. Pacifico, N. L. Bragazzi, P. Malagoli, G. Fabbrocini, E. Bonifazi, F. Mazzotta, C. Lovati, P. Savoia, L. C. Gironi, M. Morello, T. Davidson, A. Watad, F. Goker, C. Mortellaro, M. Del Fabbro

Research output: Contribution to journal › Article › peer-review

Abstract

OBJECTIVE: COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated. PATIENTS AND METHODS: This was a multicenter, case-control, observational study that compared the family impact of COVID-19 toes vs. psoriasis (PsO). We enrolled 46 pediatric patients (23 with psoriasis and 23 with COVID-19 toes, age and gender matched) and their parents/caregivers that had to fill the Dermatitis Family Impact (DFI) questionnaire. RESULTS: DFI index did not differ significantly between both subgroups (p=0.48), and in psoriatic patients did not correlate with both Psoriasis Area Severity Index (PASI) (p=0.59) and itch-VAS (p=0.16). CONCLUSIONS: COVID-19 toes, a transitory dermatosis, exerted a similar impact/perturbation on family dynamics than PsO, a well-known stigmatizing, chronic inflammatory dermatosis.

Original language	English
Pages (from-to)	87-93
Number of pages	7
Journal	European Review for Medical and Pharmacological Sciences
Volume	26
Issue number	3
DOIs	https://doi.org/10.26355/EURREV_202212_30798
State	Published - Dec 2022
Externally published	Yes

Bibliographical note

Publisher Copyright:
© 2022 Verduci Editore s.r.l. All rights reserved.

Keywords

Chilblain-like lesions
COVID-19 toes
Dermatitis family impact
Pediatrics
Psoriasis

ASJC Scopus subject areas

Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.26355/EURREV_202212_30798

Cite this

Damiani, G., Finelli, R., Kridin, K., Pacifico, A., Bragazzi, N. L., Malagoli, P., Fabbrocini, G., Bonifazi, E., Mazzotta, F., Lovati, C., Savoia, P., Gironi, L. C., Morello, M., Davidson, T., Watad, A., Goker, F., Mortellaro, C., & Del Fabbro, M. (2022). Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population. European Review for Medical and Pharmacological Sciences, 26(3), 87-93. https://doi.org/10.26355/EURREV_202212_30798

@article{d485ca9c73cb4cf9b8fc0a5c9244b81d,

title = "Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population",

abstract = "OBJECTIVE: COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated. PATIENTS AND METHODS: This was a multicenter, case-control, observational study that compared the family impact of COVID-19 toes vs. psoriasis (PsO). We enrolled 46 pediatric patients (23 with psoriasis and 23 with COVID-19 toes, age and gender matched) and their parents/caregivers that had to fill the Dermatitis Family Impact (DFI) questionnaire. RESULTS: DFI index did not differ significantly between both subgroups (p=0.48), and in psoriatic patients did not correlate with both Psoriasis Area Severity Index (PASI) (p=0.59) and itch-VAS (p=0.16). CONCLUSIONS: COVID-19 toes, a transitory dermatosis, exerted a similar impact/perturbation on family dynamics than PsO, a well-known stigmatizing, chronic inflammatory dermatosis.",

keywords = "Chilblain-like lesions, COVID-19 toes, Dermatitis family impact, Pediatrics, Psoriasis",

author = "G. Damiani and R. Finelli and K. Kridin and A. Pacifico and Bragazzi, {N. L.} and P. Malagoli and G. Fabbrocini and E. Bonifazi and F. Mazzotta and C. Lovati and P. Savoia and Gironi, {L. C.} and M. Morello and T. Davidson and A. Watad and F. Goker and C. Mortellaro and {Del Fabbro}, M.",

year = "2022",

month = dec,

doi = "10.26355/EURREV_202212_30798",

language = "English",

volume = "26",

pages = "87--93",

journal = "European Review for Medical and Pharmacological Sciences",

issn = "1128-3602",

publisher = "Verduci Editore s.r.l",

number = "3",

}

Damiani, G, Finelli, R, Kridin, K, Pacifico, A, Bragazzi, NL, Malagoli, P, Fabbrocini, G, Bonifazi, E, Mazzotta, F, Lovati, C, Savoia, P, Gironi, LC, Morello, M, Davidson, T, Watad, A, Goker, F, Mortellaro, C & Del Fabbro, M 2022, 'Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population', European Review for Medical and Pharmacological Sciences, vol. 26, no. 3, pp. 87-93. https://doi.org/10.26355/EURREV_202212_30798

Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population. / Damiani, G.; Finelli, R.; Kridin, K. et al.
In: European Review for Medical and Pharmacological Sciences, Vol. 26, No. 3, 12.2022, p. 87-93.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated

T2 - insights from a case-control study targeting the pediatric population

AU - Damiani, G.

AU - Finelli, R.

AU - Kridin, K.

AU - Pacifico, A.

AU - Bragazzi, N. L.

AU - Malagoli, P.

AU - Fabbrocini, G.

AU - Bonifazi, E.

AU - Mazzotta, F.

AU - Lovati, C.

AU - Savoia, P.

AU - Gironi, L. C.

AU - Morello, M.

AU - Davidson, T.

AU - Watad, A.

AU - Goker, F.

AU - Mortellaro, C.

AU - Del Fabbro, M.

PY - 2022/12

Y1 - 2022/12

N2 - OBJECTIVE: COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated. PATIENTS AND METHODS: This was a multicenter, case-control, observational study that compared the family impact of COVID-19 toes vs. psoriasis (PsO). We enrolled 46 pediatric patients (23 with psoriasis and 23 with COVID-19 toes, age and gender matched) and their parents/caregivers that had to fill the Dermatitis Family Impact (DFI) questionnaire. RESULTS: DFI index did not differ significantly between both subgroups (p=0.48), and in psoriatic patients did not correlate with both Psoriasis Area Severity Index (PASI) (p=0.59) and itch-VAS (p=0.16). CONCLUSIONS: COVID-19 toes, a transitory dermatosis, exerted a similar impact/perturbation on family dynamics than PsO, a well-known stigmatizing, chronic inflammatory dermatosis.

AB - OBJECTIVE: COVID-19 toes represent the main dermatological COVID-19 cutaneous manifestation in pediatric patients. Its diagnosis exposes the whole family to social stigma and this aspect was not previously evaluated. PATIENTS AND METHODS: This was a multicenter, case-control, observational study that compared the family impact of COVID-19 toes vs. psoriasis (PsO). We enrolled 46 pediatric patients (23 with psoriasis and 23 with COVID-19 toes, age and gender matched) and their parents/caregivers that had to fill the Dermatitis Family Impact (DFI) questionnaire. RESULTS: DFI index did not differ significantly between both subgroups (p=0.48), and in psoriatic patients did not correlate with both Psoriasis Area Severity Index (PASI) (p=0.59) and itch-VAS (p=0.16). CONCLUSIONS: COVID-19 toes, a transitory dermatosis, exerted a similar impact/perturbation on family dynamics than PsO, a well-known stigmatizing, chronic inflammatory dermatosis.

KW - Chilblain-like lesions

KW - COVID-19 toes

KW - Dermatitis family impact

KW - Pediatrics

KW - Psoriasis

UR - http://www.scopus.com/inward/record.url?scp=85145344840&partnerID=8YFLogxK

U2 - 10.26355/EURREV_202212_30798

DO - 10.26355/EURREV_202212_30798

M3 - Article

C2 - 36591876

AN - SCOPUS:85145344840

SN - 1128-3602

VL - 26

SP - 87

EP - 93

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

IS - 3

ER -

Damiani G, Finelli R, Kridin K, Pacifico A, Bragazzi NL, Malagoli P et al. Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population. European Review for Medical and Pharmacological Sciences. 2022 Dec;26(3):87-93. doi: 10.26355/EURREV_202212_30798

Chilblain-like lesions (COVID-19 toes) have the same impact on family members than psoriasis systemically treated: insights from a case-control study targeting the pediatric population

Abstract

Bibliographical note

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this